JB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D'Elia, M. A.
Right arrow Articles by Brown, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D'Elia, M. A.
Right arrow Articles by Brown, E. D.

 Previous Article  |  Next Article 

Journal of Bacteriology, June 2006, p. 4183-4189, Vol. 188, No. 12
0021-9193/06/$08.00+0     doi:10.1128/JB.00197-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Lesions in Teichoic Acid Biosynthesis in Staphylococcus aureus Lead to a Lethal Gain of Function in the Otherwise Dispensable Pathway§

Michael A. D'Elia,1 Mark P. Pereira,1 Yu Seon Chung,1 Wenjun Zhao,2 Andrew Chau,2 Teresa J. Kenney,2,{dagger} Mark C. Sulavik,2,{ddagger} Todd A. Black,2 and Eric D. Brown1*

Antimicrobial Research Centre and Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8N 3Z5, Canada,1 Schering-Plough Research Institute, Kenilworth, New Jersey 07033-05302

Received 6 February 2006/ Accepted 31 March 2006

An extensive study of teichoic acid biosynthesis in the model organism Bacillus subtilis has established teichoic acid polymers as essential components of the gram-positive cell wall. However, similar studies pertaining to therapeutically relevant organisms, such as Staphylococcus aureus, are scarce. In this study we have carried out a meticulous examination of the dispensability of teichoic acid biosynthetic enzymes in S. aureus. By use of an allelic replacement methodology, we examined all facets of teichoic acid assembly, including intracellular polymer production and export. Using this approach we confirmed that the first-acting enzyme (TarO) was dispensable for growth, in contrast to dispensability studies in B. subtilis. Upon further characterization, we demonstrated that later-acting gene products (TarB, TarD, TarF, TarIJ, and TarH) responsible for polymer formation and export were essential for viability. We resolved this paradox by demonstrating that all of the apparently indispensable genes became dispensable in a tarO null genetic background. This work suggests a lethal gain-of-function mechanism where lesions beyond the initial step in wall teichoic acid biosynthesis render S. aureus nonviable. This discovery poses questions regarding the conventional understanding of essential gene sets, garnered through single-gene knockout experiments in bacteria and higher organisms, and points to a novel drug development strategy targeting late steps in teichoic acid synthesis for the infectious pathogen S. aureus.


* Corresponding author. Mailing address: Department of Biochemistry and Biomedical Sciences, Health Science Centre 4H32, 1200 Main St., W. Hamilton, ON L8N 3Z5, Canada. Phone: (905) 525-9140, ext. 22392. Fax: (905) 522-9033. E-mail: ebrown{at}mcmaster.ca.

§ Supplemental material for this article may be found at http://jb.asm.org/.

{dagger} Present address: Department of Biology, Bowdoin College, Brunswick, ME 04011.

{ddagger} Present address: Pfizer Global Research and Development, Ann Arbor, MI 48105.


Journal of Bacteriology, June 2006, p. 4183-4189, Vol. 188, No. 12
0021-9193/06/$08.00+0     doi:10.1128/JB.00197-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Appl. Environ. Microbiol. Infect. Immun. Eukaryot. Cell
Mol. Cell. Biol. J. Virol. Microbiol. Mol. Biol. Rev.
ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.